
Pfizer Ltd. Reports Flat Quarterly Financial Trend Despite Record Sales and Profitability
2026-11-04 08:00:25Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has reported its September 2026 quarter results, marking record highs in net sales, profitability, and earnings per share. However, despite these impressive figures, the company’s overall financial trend has shifted from positive to flat, signalling a cautious outlook amid broader market challenges and relative underperformance against benchmarks.
Read More
Pfizer Ltd. is Rated Sell by MarketsMOJO
2026-10-26 10:10:26Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read More
Pfizer Ltd. is Rated Sell by MarketsMOJO
2026-10-15 10:10:40Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Markets Rally, But Pfizer Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-10-08 10:15:49While broader indices have shown signs of recovery, Pfizer Ltd. has continued its downward trajectory, hitting a fresh 52-week low of Rs 3,792.5 on 8 Oct 2026. This decline extends the stock’s underperformance relative to the Sensex, which itself is hovering near its own 52-week low but has not fallen as sharply.
Read More
Pfizer Ltd. is Rated Sell by MarketsMOJO
2026-10-04 10:10:27Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read More
Five-Day Slide Pushes Pfizer. to Fresh 52-Week Low of Rs 3,825.9
2026-10-01 12:37:17For the fifth consecutive session, Pfizer. has closed lower, culminating in a new 52-week low of Rs 3,825.9 on 1 Oct 2026. This decline comes amid a broader market downturn, but the stock’s underperformance has been notably sharper, reflecting a complex interplay of valuation concerns and mixed financial signals.
Read More
Five Consecutive Losses Push Pfizer Ltd. to a New 52-Week Low
2026-09-29 15:06:28For the fifth straight session, Pfizer Ltd. closed lower, breaching its 52-week low at Rs 3,924.05 on 29 Sep 2026, marking a significant decline amid broader market weakness.
Read More
Pfizer Ltd. is Rated Sell by MarketsMOJO
2026-09-23 10:10:46Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreBoard Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026.
03-Nov-2026 | Source : BSEPlease find enclosed unaudited financial results for the quarter and half year ended September 30 2026 along with the limited review report.
Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026.
26-Oct-2026 | Source : BSEPfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday November 3 2026 to consider approve and take on record the unaudited financial results for the quarter and half year ended September 30 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Oct-2026 | Source : BSEPlease find attached Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.
Corporate Actions
No Upcoming Board Meetings
Pfizer Ltd. has declared 750% dividend, ex-date: 17 Jul 26
No Splits history available
No Bonus history available
No Rights history available
